Effect of Mu opioid receptor blockade on alcohol intake in rats bred for high alcohol drinking

Pharmacology Biochemistry and Behavior

Volumn 59, Issue 3, 1998, Pages 627-635

  Krishnan Sarin, S ^a,d   Wand, G S ^b   Li, X W ^a   Portoghese, P S ^c   Froehlich, J C ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alcohol drinking; Alcohol preference; Beta FNA; Genetic selection; mRNA; Opioid antagonists; Opioid receptors; Pituitary gland; Rats

Indexed keywords

BETA ENDORPHIN; BETA FUNALTREXAMINE; MESSENGER RNA; MU OPIATE RECEPTOR; OPIATE ANTAGONIST;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ARTICLE; GENE EXPRESSION; GENETIC PREDISPOSITION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ALCOHOL DRINKING; ANIMALS; AUTORADIOGRAPHY; GENE EXPRESSION REGULATION; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; PITUITARY GLAND; PRO-OPIOMELANOCORTIN; RATS; RATS, INBRED STRAINS; RECEPTORS, OPIOID, MU; RNA, MESSENGER;

ANIMALIA; EUKARYOTA;

EID: 0032030917     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00474-7     Document Type: Article

References (80)

1. Aceto M. D., Dewey W. L., Portoghese P. S., Takemori A. E. Effects of B-funaltrexamine (B-FNA) on morphine dependence in rats and monkeys. Eur. J. Pharmacol. 123:1986;387-393.
2. Allen A. M., Harris R. A. Neurochemical studies of genetic differences in alcohol action. Crabbe J. C., Harris R. A. The genetic basis for alcohol and drug actions. 1991;105-152 Plenum Press, New York.
3. Altshuler H. L., Phillips P. E., Feinhandler D. A Alteration of ethanol self-administration by naltrexone. Life. Sci. 26:1980;679-688.
4. Angelogianni P., Gianoulakis C. Chronic ethanol increases Proopiomelanocortin gene expression in the rat hypothalamus. Neuroendocrinology. 57:1993;106-114.
5. Barry H., Wallgren H. A. A further note on preparing alcohol solutions. Q. J. Stud. Alcohol. 29:1968;176-178.
6. Bloom F. E. The endorphins. A growing family of pharmacologically pertinent peptides Annu. Rev. Pharmacol. Toxicol. 23:1983;151-170.
7. Cadoret R. J., Cain C. A., Grove W. M. Development of alcoholism in adoptees raised apart from alcoholic biologic relatives. Arch. Gen. Psychiatry. 37:1980;561-563.
8. Chang K.-J., Cooper B. R., Hazum E., Cuatrecasas P. Multiple opiate receptors. Different regional distribution in the brain and differential binding of opiates and opioid peptides Mol. Pharmacol. 16:1979;91-104.
9. Chang K.-J., Cuatrecasas P. Heterogeneity and properties of opiate receptors. Fed. Proc. 40:1981;2729-2734.
10. Childers S. R., Creese I., Snowman A. M., Snyder S. H. Opiate receptor binding affected differentially by opiates and opioid peptides. Eur. J. Pharmacol. 55:1979;11-18.
11. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
12. Cloninger C. R., Bohman C., Sigvardsson S. Inheritance of alcohol abuse. Cross-fostering analysis of adopted men Arch. Gen. Psychiatry. 38:1981;861-868.
13. Corbett A. D., Paterson S. J., Kosterlitz H. W. Selectivity of ligands for opioid receptors. Herz A. Handbook of experimental pharmacology, vol. 104. 1993;645-679 Springer Verlag, New York.
14. Cotton N. S. The familial incidence of alcoholism. J. Stud. Alcohol. 40:1979;89-116.
15. Crabbe J. C. Genetic animal models in the study of alcoholism. Alcohol. Clin. Exp. Res. 13:1989;120-127.
16. Dave J. R., Eiden L. E., Karanian J. W., Eskay R. L. Ethanol exposure decreases pituitary corticotropin-releasing factor binding, adenylate cyclase activity, proopiomelanocortin biosynthesis, and plasma B-endorphin levels in the rat. Endocrinology. 118:1986;280-286.
17. De Waele J.-P., Papachristou D. N., Gianoulakis C. The alcohol-preferring c57BL/6 mice present an enhanced sensitivity of the hypothalamic B-endorphin system to ethanol than the alcohol-avoiding DBA/2 mice. J. Pharmacol. Exp. Ther. 261:1992;788-794.
18. DiChiara G., North R. A. Neurobiology of opiate abuse. Trends Pharmacol. Sci. 13:1992;185-211.
19. Dietrich R. A., Dunwiddie T. V., Harris R. A., Erwin V. G. Mechanism of action of alcohol. Initial central nervous system actions Pharmacol. Rev. 41:1989;491-537.
20. Froehlich J. C. Interactions between alcohol and the endogenous opioid system. Zakhari S. Alcohol and the endocrine system, Monograph 23, National Institute on Alcohol Abuse and Alcoholism Research Monograph Series. 1993;21-35 U.S. Government Printing Office, Washington, DC.
21. Froehlich J. C. Genetic factors in alcohol self-administration. J. Clin. Psychiatry. 56:1995;15-23.
22. Froehlich J. C., Harts J., Lumeng L., Li T.-K. Naloxone attenuation of voluntary alcohol consumption. Lindros K. O., Ylikahari R., Kiianmaa K. Advances in biomedical alcohol research. 1987;333-337 Pergamon Press, New York.
23. Froehlich J. C., Harts J., Lumeng L., Li T.-K. Differences in response to the aversive properties of ethanol in rats selectively bred for oral ethanol preference. Pharmacol. Biochem. Behav. 31:1988;215-222.
24. Froehlich J. C., Harts J., Lumeng L., Li T.-K. Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference. Pharmacol. Biochem. Behav. 35:1990;385-390.
25. Froehlich J. C., Li T.-K. Enkephalinergic involvement in voluntary drinking of alcohol. Reid L. D. Opioids, bulimia, alcohol abuse and alcoholism. 1990;217-228 Springer Verlag, New York.
26. Froehlich J. C., Li T.-K. Opioid peptides. Galanter M. Recent developments in alcoholism, vol. 11. Ten years of progress. 1993;187-205 Plenum Publishing, New York.
27. Froehlich J. C., Li T.-K. Opioid involvement in alcohol drinking. Strand F. L., Beckwith W., Chronwall B., Sandman S. A. Models of neuropeptide action, vol. 739. 1994;156-167 Annals of the New York Academy of Sciences, New York.
28. Froehlich J. C., Wand G. The neurobiology of ethanol-opioid interactions in ethanol reinforcement. Alcohol. Clin. Exp. Res. 20:1996;181A-186A.
29. Froehlich J. C., Zweifel M., Harts J., Lumeng L., Li T.-K. Importance of delta opioid receptors in maintaining high alcohol drinking. Psychopharmacology (Berlin). 103:1991;463-467.
30. Gianoulakis C. Characterization of the effects of acute ethanol administration on the release of B-E peptides by the rat hypothalamus. Eur. J. Pharmacol. 180:1990;21-29.
31. Gianoulakis C., Barcomb A. Effect of acute ethanol in vivo and in vitro on the B-endorphin system in the rat. Life Sci. 40:1987;19-28.
32. Gianoulakis C., Beliveau D., Angelogianni P., Meaney M., Thavundayil J., Tawar V., Dumas M. Different pituitary β-endorphin and adrenal cortisol response to ethanol in individuals with high and low risk for future development of alcoholism. Life Sci. 45:1989;1097-1109.
33. Gianoulakis C., Krishnan B., Thavundayil J. Enhanced sensitivity of pituitary B-endorphin to ethanol in subjects at high risk of alcoholism. Arch. Gen. Psychiatry. 53:1996;250-257.
34. Gianoulakis C., Chan J. S. D., Kalant H., Cretien M. Chronic ethanol treatment alters the biosynthesis of beta-endorphin by the rat neurointermediate lobe. Can. J. Physiol. Pharmacol. 61:1983;967-976.
35. Gianoulakis C., Hutchison W. D., Kalant H. Effect of ethanol treatment and withdrawal on biosynthesis and processing of proopiomelanocortin by the rat neurointermediate lobe. Endocrinology. 122:1988;817-825.
36. Goodwin D. W. Alcoholism and genetics. Arch. Gen. Psychiatry. 42:1985;171-174.
37. Hubbell C. L., Czirr S. A., Hunter G. A., Beaman C. M., LeCann N. C., Reid L. D. Consumption of ethanol solution is potentiated by morphine and attenuated by naloxone persistently across repeated daily administration. Alcohol. 3:1986;39-54.
38. Hyytia P. Involvement of mu-opioid receptors in alcohol drinking by alcohol-preferring AA rats. Pharmacol. Biochem. Behav. 45:1993;697-701.
39. Keith L. D., Crabbe J. C., Robertson L. M., Kendall J. W. Ethanol-stimulated endorphin and corticotropin secretion in vitro. Brain Res. 367:1986;222-229.
40. Khanna J. M., Kalant H., Bustos G. Effects of chronic intake of ethanol on rate of ethanol metabolism. II. Influence of sex and schedule of ethanol administration. Can. J. Physiol. Pharmacol. 45:1967;777-785.
41. Kosterlitz H. W., Paterson S. J. Types of opioid receptors. Relation to antinociception Philos. Trans. R. Soc. Lond. [Biol.]. 308:1985;291-297.
42. Krishnan-Sarin S., Jing S.-L, Kurtz D. L., Zweifel M., Portoghese P. S., Li T.-K., Froehlich J. C. The delta opioid receptor antagonist naltrindole attenuates both alcohol and saccharin intake in rats selectively bred for alcohol preference. Psychopharmacology (Berlin). 120:1995;177-185.
43. 2 opioid receptor antagonist naltriben selectively attenuates alcohol intake in rats bred for alcohol preference. Pharmacol. Biochem. Behav. 52:1995;153-159.
44. Le A. D., Poulos C. X., Quan B., Chow S. The effects of selective blockade of delta and mu opiate receptors on ethanol consumption by C57BL/6 mice in a restricted access paradigm. Brain Res. 630:1993;330-332.
45. Li T.-K., Lumeng L., Doolittle P., Carr L. G. Molecular associations of alcohol-seeking behavior in rat lines selectively bred for high and low voluntary ethanol drinking. Alcohol Alcohol. Suppl. 1:1991;121-124.
46. Li T.-K., Lumeng L., McBride W. J., Waller M. B. Indiana selection studies on alcohol-related behaviors. NIAAA Research Monograph No. 1981;171-191 U.S. Department of Health and Human Services, 6, Development of animal models as pharmacogenetic tools. Rockville, MD.
47. Li T.-K., McBride W. J. Pharmacogenetic models of alcoholism. Clin. Neurosci. 3:1995;182-188.
48. Li X.-W., Li T.-K., Froehlich J. C. Alcohol alters preproenkephalin mRNA content in the shell and core of the nucleus accumbens. Alcohol. Clin. Exp. Res. 20:1996;53A.
49. Lord J. A., Waterfield A. A., Hughes J., Kosterlitz H. W. Endogenous opioid peptides. Multiple agonists and receptors Nature. 267:1997;49.
50. Lumeng L., Hawkins T. D., Li, T.-K New strains of rats with alcohol preference and nonpreference. Thurman R. G., Williamson J. R., Drott H. R., Chance B. Alcohol and aldehyde metabolizing systems, vol. 3. 1977;537-544 Academic Press, New York.
51. Lumeng, L.; Penn, P. E.; Gaff, T. M.; Hawkins, T. D.; Li, T.-K.: Further characterization of a new rat strain with high alcohol preference. In: Seixas, F. A., ed. Currents in alcoholism, biological, biochemical and clinical studies, vol. III. New York: Grune and Stratton; 1978:22-23.
52. Marfaing-Jallat P., Miceli C., LeMagnen J. Decrease in ethanol consumption by naloxone in naive and dependent rats. Pharmacol. Biochem. Behav. 18:1983;537-539.
53. Martin W. R., Eades C. G., Thompson J. A., Huppler R. E., Gilbert, P. E The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197:1976;517-532.
54. Messing R. B., Portoghese P. S., Takemori A. E., Sparber S. B. Antagonism of morphine-induced behavioral suppression by opiate receptor alkylators. Pharmacol. Biochem. Behav. 16:1982;621-626.
55. Murphy J. M., Gatto G. J., Waller M. B., McBride W. J., Lumeng L., Li T.-K. Effects of scheduled access on ethanol intake by the alcohol-preferring (P) line of rats. Alcohol. 3:1986;331-336.
56. Myers R. D., Borg S., Mossberg R. Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey. Alcohol. 3:1986;383-388.
57. O'Malley S. S., Jaffe A. J., Chang G., Schottenfeld R. S., Meyer R. E., Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch. Gen. Psychiatry. 49:1992;881-887.
58. Pastorcic M., Boyadjieva N., Sarkar D. K. Comparison of the effects of alcohol and acetaldehyde on proopiomelanocortin mRNA levels and beta-endorphin secretion from hypothalamic neurons in primary cultures. Mol. Cell. Neurosci. 5:1994;580-586.
59. Patel V. A., Pohorecky L. A. Interaction of stress and ethanol. Effect on B-endorphin and catecholamines Alcohol. Clin. Exp. Res. 12:1988;785-789.
60. Portoghese P. S. Some principles in the design of more selective pharmacological agents. Application to multiple opioid receptors Am. J. Pharmaceut. Ed. 51:1987;1-7.
61. Portoghese P. S., Larson D. L., Sayre L. M., Fries D. S., Takemori A. E. A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities. J. Med. Chem. 23:1980;233-234.
62. Raynor K., Kong H., Chen Y., Yasuda K., Yu L., Graeme I. B., Reisine T. Pharmacological characterization of the cloned k-, delta and mu-opioid receptors. Mol. Pharmacol. 45:1994;330-334.
63. Reddy B. V., Sarkar D. K. Effect of alcohol, acetaldehyde, and salsolinol on beta-endorphin secretion from the hypothalamic neurons in primary cultures. Alcohol. Clin. Exp. Res. 17:1993;1261-1267.
64. Reid L. D., Hunter G. A. Morphine and naloxone modulate intake of ethanol. Alcohol. 1:1984;33-37.
65. Scanlon M. N., Lazar-Wesley E., Grant K. A., Kunos G. Proopiomelanocortin messenger RNA is decreased in the mediobasal hypothalamus of rats made dependent on ethanol. Alcohol. Clin. Exp. Res. 16:1992;1147-1151.
66. Seizinger B. R., Bovermann K., Maysinger D., Hollt V., Herz A. Differential effects of acute and chronic ethanol treatment on particular opioid peptide systems in discrete regions of rat brain and pituitary. Pharmacol. Biochem. Behav. 18:1983;361-369.
67. Seizinger B. R., Hollt V., Herz A. Effects of chronic ethanol treatment on the in vitro biosynthesis of pro-opiomelanocortin and its posttranslational processing to B-endorphin in the intermediate lobe of the rat pituitary. J. Neurochem. 43:1984;607-613.
68. Self D. W., Stein L. Receptor subtypes in opioid and stimulant reward. Pharmacol. Toxicol. 70:1992;87-94.
69. Shippenberg T. S., Herz A., Spanagel R., Bals-Kubik R., Stein C. Conditioning of opioid reinforcement. Neuroanatomical and neurochemical substrates Ann. NY Acad. Sci. 654:1992;347-356.
70. Stein L. Reward transmitters. Catecholamines and opioid peptides Lipton M. A., DiMascio A., Killam K. F. Psychopharmacology. A generation of progress:1978;569-581 Raven Press, New York.
71. Takemori A. E., Larson D. L., Portoghese P. S. The irreversible narcotic antagonistic and reversible agonistic properties of the fumarate methyl ester derivative of naltrexone. Eur. J. Pharmacol. 70:1981;445-451.
72. Thiagarajan A. B., Mefford I. N., Eskay R. L. Single-dose ethanol administration activates the hypothalamic-pituitary-adrenal axis. Exploration of the mechanism of action Neuroendocrinology. 50:1989;427-432.
73. Uhler M., Herbert E. Complete amino acid sequence of mouse proopiomelanocortin derived from the nucleotide sequence of proopiomelanocortin cDNA. J. Biol. Chem. 258:1983;257-261.
74. Volpicelli J. R., Alterman A. I., Hayashida M., O'Brien C. P. Naltrexone in the treatment of alcohol dependence. Arch. Gen. Psychiatry. 49:1992;876-880.
75. Wand G. S. Ethanol differentially regulates proadrenocorticotropin/endorphin production and corticosterone secretion in LS and SS lines of mice. Endocrinology. 124:1989;518-525.
76. Wand G. S., Levine M. A. Hormonal tolerance to ethanol is associated with decreased expression of the GTP-binding protein Gsa adenylyl cyclase activity in ethanol-treated LS mice. Alcohol. Clin. Exp. Res. 15:1991;705-710.
77. Ward S. J., Fries D. S., Larson D. L., Portoghese P. S., Takemori A. E. Opioid receptor binding characteristics of the nonequilibrium mu antagonist, beta-funaltrexamine (Beta-FNA). Eur. J. Pharmacol. 107:1985;323-330.
78. Ward S. J., Portoghese P. S., Takemori A. E. Pharmacological characterization in vivo of the novel opiate Beta-Funaltrexamine. J. Pharmacol. Exp. Ther. 220:1982;494-498.
79. Weiss F., Mitchiner M., Bloom F. E., Koob G. F. Free-choice responding for ethanol vs. water in alcohol-preferring (P) and unselected Wistar rats is differentially modified by naloxone, bromocriptine, and methysergide. Psychopharmacology (Berlin). 101:1990;178-186.
80. Winer B. J. Statistical principles in experimental design. 2:1971;McGraw-Hill, New York.